Stay Ahead in RNAi: Join 80+ Leaders Shaping 2026 Innovation
January 27-29, 2026 | Boston, MA – With the exciting news of Novartis acquiring Avidity Biosciences, SanegeneBio and Eli Lilly’s partnership worth $1.2B to develop RNAi therapeutics for metabolic disease, the RNAi industry is hotter than ever! As breakthroughs like this are becoming more frequent, how will you ensure your RNAi pipeline stays ahead of the curve and not left behind?
The 7th RNAi-Based Therapeutics Summit (January 27-29, 2026 | Boston, MA) is the essential industry forum to connect your industry peers who are driving the excitement and next era of RNAi.
If you’re keen to benchmark your strategy with 80+ RNAi leaders, visit our website to see how you can contribute to the conversation.
Hear from your RNAi Peers:
“The talks were timely and exceptionally well-organized. The content was comprehensive and addressed several crucial areas within biology and chemistry.” – Novartis
“The access to the experts and companies that are transforming the RNAi segment was exceptional. I have never experienced an event where the expertise presenting or attending was so accessible for continued discussion. I got answers to so many questions that this event was absolutely worth my time in attending.” – Nuago Therapeutics
Uncover the potential of RNAi in 2026 here: https://ter.li/x0kzfc
2026 Event Highlights Below:
30+ Data-Driven Presentations including:
- Reversing Time: Exploring the Utility of RNAi for Anti-Aging Applications
Paul Lawrence, Executive Director, Biocogent - Utilizing LEADtm RNAi Technology to Treat Obesity and Metabolic Disease
Weimin Wang, Founder & CEO, Sanegene Bio - Breaking through the Blood-Brain Barrier with Trojan Horse Formulations
Yacoub Habib, CEO, Ophidion
Panel Discussion Exploring the Future of RNAi & Precision Medicine
Explore synergizing AI, combination therapies and multi-target silencing to future-proof your pipeline and lead the next wave of transformative treatments
Canary Cure | RNatives | Ceria Therapeutics | Judo Biosciences | Alnylam
2 Interactive Pre-Conference Workshops
From maximizing novel in silico strategies to harness data-driven approaches, to understanding RNAi therapeutic chemical engineering for enhanced extrahepatic delivery, these workshops will allow you to deep-dive into the techniques of Gensaic, RNatives, Ceria Therapeutics, and DoriNano.
Key Details:
January 27-29, 2026
Revere Hotel Boston Common, Boston, MA
Official Brochure: https://ter.li/x0kzfc
Registration Link: https://ter.li/kakwfw
2026 Partners: https://ter.li/lvnluw
If you are interested in attending, feel free to reach out to info@hansonwade.com to discover more about how to join the conversation.